GJC1
geneOn this page
Also known as CX45
Summary
GJC1 (gap junction protein gamma 1, HGNC:4280) is a protein-coding gene on chromosome 17q21.31, encoding Gap junction gamma-1 protein (P36383). Structural component of the gap junction, a specialized intercellular structure consisting of a cluster of closely packed pairs of transmembrane channels, the connexons, that allow passage of small molecules and electrical signals between neighboring cells.
This gene is a member of the connexin gene family. The encoded protein is a component of gap junctions, which are composed of arrays of intercellular channels that provide a route for the diffusion of low molecular weight materials from cell to cell. Alternatively spliced transcript variants encoding the same isoform have been described.
Source: NCBI Gene 10052 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 42 total
- MANE Select transcript:
NM_005497
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:4280 |
| Approved symbol | GJC1 |
| Name | gap junction protein gamma 1 |
| Location | 17q21.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CX45 |
| Ensembl gene | ENSG00000182963 |
| Ensembl biotype | protein_coding |
| OMIM | 608655 |
| Entrez | 10052 |
Gene structure
Transcript identifiers
Ensembl transcripts: 20 — 20 protein_coding
ENST00000330514, ENST00000586267, ENST00000586347, ENST00000587113, ENST00000587239, ENST00000590758, ENST00000591424, ENST00000592524, ENST00000907279, ENST00000907280, ENST00000907281, ENST00000907282, ENST00000907284, ENST00000920109, ENST00000920110, ENST00000920111, ENST00000920112, ENST00000920113, ENST00000964185, ENST00000964186
RefSeq mRNA: 2 — MANE Select: NM_005497
NM_001080383, NM_005497
CCDS: CCDS11487
Canonical transcript exons
ENST00000592524 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001311342 | 44798448 | 44805837 |
| ENSE00001515699 | 44807394 | 44807469 |
| ENSE00001515700 | 44830062 | 44830287 |
Expression profiles
Bgee: expression breadth ubiquitous, 229 present calls, max score 94.91.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.5710 / max 74.8246, expressed in 1130 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 166400 | 3.5710 | 1130 |
| 166401 | 1.4925 | 542 |
Top tissues by expression
275 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cauda epididymis | UBERON:0004360 | 94.91 | gold quality |
| seminal vesicle | UBERON:0000998 | 93.81 | gold quality |
| cartilage tissue | UBERON:0002418 | 91.69 | gold quality |
| secondary oocyte | CL:0000655 | 91.19 | gold quality |
| adult organism | UBERON:0007023 | 90.90 | gold quality |
| visceral pleura | UBERON:0002401 | 90.25 | gold quality |
| saphenous vein | UBERON:0007318 | 89.84 | gold quality |
| placenta | UBERON:0001987 | 88.76 | gold quality |
| ventricular zone | UBERON:0003053 | 88.53 | gold quality |
| colonic epithelium | UBERON:0000397 | 88.50 | gold quality |
| myometrium | UBERON:0001296 | 87.89 | gold quality |
| cortical plate | UBERON:0005343 | 87.76 | gold quality |
| urethra | UBERON:0000057 | 87.60 | gold quality |
| ganglionic eminence | UBERON:0004023 | 87.51 | gold quality |
| parietal pleura | UBERON:0002400 | 87.50 | gold quality |
| oocyte | CL:0000023 | 87.31 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 86.89 | gold quality |
| pleura | UBERON:0000977 | 86.81 | gold quality |
| body of uterus | UBERON:0009853 | 86.18 | gold quality |
| stromal cell of endometrium | CL:0002255 | 86.11 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 86.07 | gold quality |
| decidua | UBERON:0002450 | 85.97 | gold quality |
| lower lobe of lung | UBERON:0008949 | 85.84 | gold quality |
| sural nerve | UBERON:0015488 | 84.88 | gold quality |
| heart right ventricle | UBERON:0002080 | 84.23 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 83.40 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.89 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.86 | gold quality |
| apex of heart | UBERON:0002098 | 82.42 | gold quality |
| uterus | UBERON:0000995 | 81.80 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7249 | yes | 39.46 |
| E-ANND-3 | yes | 13.63 |
| E-MTAB-6678 | yes | 11.48 |
| E-GEOD-111727 | no | 173.78 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
180 targeting GJC1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
Literature-anchored findings (GeneRIF, showing 25)
- Data suggest that the dynamic changes of connexins 43, 40 and 45 during mouse cardiac development appear to be mirrored in the human. (PMID:12064615)
- abnormal expression of connexin43 and connexin45 in nasopharynx tissues may be associated with cancerization and squamatization of human nasopharynx tissue (PMID:12452056)
- mRNA levels of connexins in different sizes of luteinized normal and hyperstimulated follicles. (PMID:14667880)
- The staining patterns for Cx45 rather were typified by granular cytoplasmic staining. (PMID:14766937)
- Cx45 has a complex binding interaction with zonula occludens-1 (ZO-1) that involves either an extended carboxyl terminal domain or two distinct binding sites. (PMID:16463142)
- Cx40/Cx45 junctions demonstrate electrical signal transfer asymmetry that can be modulated between unidirectional and bidirectional by small changes in the difference between holding potentials of the coupled cells. (PMID:17189315)
- a cross-talk between CFTR and a variety of gap junction channels. Cytoskeletal scaffolding proteins and/or other intermediate cytoplasmic proteins are likely to play a role in CFTR-connexins interaction. (PMID:17546509)
- Studies indicate that 21 different Cxs have been detected and they are generally named according to their approximate molecular mass in Kda, e.g. Cx32, Cx43 and Cx45. (PMID:19883623)
- Results show that Cx40, Cx37, Cx43 and Cx45 were expressed within the glomeruli. (PMID:20530971)
- connexin genes Gjd2 coding for mCx36, Gjc1 coding for mCx45 and Gja10 coding for mCx57 in the mouse, a subset of 4 connexin genes, including the unique GJA9 (Cx59) and GJA10 (Cx62), could be detected at least as transcript isoforms in the human retina. (PMID:20979653)
- Our data suggest that GJA7 alterations have no or low genetic relevance in nonsyndromic hearing loss in populatins from Turkey, South Africa, United Kingdom, United States, and China. (PMID:21254920)
- DNA hypermethylation of the promoter region of GJC1, encoding connexin45, is an important mechanism in silencing gene expression in colorectal cancer. (PMID:21406965)
- Study shows that fusion of a V5/6-His tag (hexa moiety M r = 0.93 kDa) to the CT segment of Cx40, Cx43 and Cx45 does not prevent the cells from forming channels. (PMID:21424225)
- Gap junctional intercellular communication in human bladder smooth muscle cells and suburothelial myofibroblastsdepend of Cx43 rather than on Cx45. (PMID:21674053)
- Results found that the expression of Cx26 and Cx45 had no prognostic value but Cx43 was upregulated in tumour epithelia and membrane Cx43 expression was associated with short overall survival time. (PMID:24788723)
- Connexin45 has much more rapid gating kinetics than connexin43 (PMID:25401181)
- Human deltoid muscle biopsies of 5 Chilean dysferlinopathy patients exhibited the presence of muscular connexins (Cx40.1, Cx43 and Cx45). (PMID:27229680)
- our data highlighted the critical role of CX45 in reprogramming and may increase the cell division rate and result in an accelerated kinetics of iPSCs production. (PMID:28352086)
- human Cx40/Cx45 and Cx43/Cx45 heterotypic gap junctions were investigated by recombinant expression in GJ deficient cells. (PMID:28760564)
- Observations involving both N- and C-domains of CaM to interact with the Cx45 peptide differ from the embraced interaction with Cx50 from another connexin family (PMID:28963343)
- The HG-stimulated proliferative capacity was abolished upon decreasing O-GlcNAcylation, which could be reversed gradually by the simultaneous overexpression of APA1 and GJC1. Therefore, GJC1 could be a potential target for preventing liver cancer in patients with diabetes. (PMID:30078215)
- Cx40 or Cx45 Gap junctions showed little changes in the extent of voltage-dependent-gating, but in both cases with a faster deactivation kinetics at high temperatures. (PMID:30594539)
- Identification of Cx45 as a Major Component of GJs in HeLa Cells. (PMID:33003547)
- Connexin45 (GJC1) loss-of-function mutation contributes to familial atrial fibrillation and conduction disease. (PMID:33429106)
- The role of the Cx43/Cx45 gap junction voltage gating on wave propagation and arrhythmogenic activity in cardiac tissue. (PMID:37684404)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Gjc1 | ENSMUSG00000034520 |
| rattus_norvegicus | Gjc1 | ENSRNOG00000048838 |
Paralogs (20): GJA8 (ENSG00000121634), GJB6 (ENSG00000121742), GJA3 (ENSG00000121743), GJA9 (ENSG00000131233), GJA10 (ENSG00000135355), GJA1 (ENSG00000152661), GJD2 (ENSG00000159248), GJB7 (ENSG00000164411), GJB2 (ENSG00000165474), GJB1 (ENSG00000169562), GJC3 (ENSG00000176402), GJD4 (ENSG00000177291), GJD3 (ENSG00000183153), GJA4 (ENSG00000187513), GJB3 (ENSG00000188910), GJB5 (ENSG00000189280), GJB4 (ENSG00000189433), GJC2 (ENSG00000198835), GJE1 (ENSG00000203733), GJA5 (ENSG00000265107)
Protein
Protein identifiers
Gap junction gamma-1 protein — P36383 (reviewed: P36383)
Alternative names: Connexin-45, Gap junction alpha-7 protein
All UniProt accessions (7): P36383, A0A654IDC0, K7EM78, K7ENT9, K7EQ14, K7ERH3, Q5H9P2
UniProt curated annotations — full annotation on UniProt →
Function. Structural component of the gap junction, a specialized intercellular structure consisting of a cluster of closely packed pairs of transmembrane channels, the connexons, that allow passage of small molecules and electrical signals between neighboring cells. Forms homotypic and heterotypic channels gated by transjunctional voltage. Involved in intercellular innate immune signaling. Mediates translocation of 2’,3’-cGAMP and 2’,5’-oligoadenylates (2-5A) second messengers from virus-infected cells to macrophages and uninfected neighboring cells to propagate and amplify the antiviral immune response.
Subunit / interactions. A connexon/hemichannel is composed of a hexamer of connexins. Forms functional homotypic gap junctions consisting of identical hemichannels both made of the same connexin type as well as heterotypic gap junctions consisting of two different hemichannels, each containing a different type of connexin. Assembles with GJA1 to form heterotypic gap junction channels. Interacts with CNST.
Subcellular location. Cell membrane. Cell junction. Gap junction.
Similarity. Belongs to the connexin family. Gamma-type subfamily.
RefSeq proteins (2): NP_001073852, NP_005488* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000500 | Connexin | Family |
| IPR002265 | Connexin45 | Family |
| IPR013092 | Connexin_N | Domain |
| IPR017990 | Connexin_CS | Conserved_site |
| IPR019570 | Connexin_CCC | Domain |
| IPR038359 | Connexin_N_sf | Homologous_superfamily |
Pfam: PF00029
Catalyzed reactions (Rhea), 2 shown:
- 2’,3’-cGAMP(out) = 2’,3’-cGAMP(in) (RHEA:66320)
- 5’-triphosphoadenylyl-(2’->5’)-adenylyl-(2’->5’)-adenosine(out) = 5’-triphosphoadenylyl-(2’->5’)-adenylyl-(2’->5’)-adenosine(in) (RHEA:85019)
UniProt features (16 total): topological domain 5, transmembrane region 4, region of interest 2, compositionally biased region 2, sequence conflict 2, chain 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 3SHW | X-RAY DIFFRACTION | 2.9 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P36383-F1 | 69.52 | 0.28 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-112303 | Electric Transmission Across Gap Junctions |
| R-HSA-190861 | Gap junction assembly |
MSigDB gene sets: 229 (showing top):
GOBP_MUSCLE_TISSUE_DEVELOPMENT, GOBP_CIRCULATORY_SYSTEM_PROCESS, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, REACTOME_MEMBRANE_TRAFFICKING, GOBP_CELL_CELL_SIGNALING, BROWNE_HCMV_INFECTION_48HR_DN, PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP, IRF7_01, GOBP_CELL_JUNCTION_ORGANIZATION, GOBP_MUSCLE_CONTRACTION, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2, GOBP_CELL_COMMUNICATION_INVOLVED_IN_CARDIAC_CONDUCTION, GOBP_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS, GOBP_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING, GOBP_CELL_CELL_SIGNALING_INVOLVED_IN_CARDIAC_CONDUCTION
GO Biological Process (16): vasculogenesis (GO:0001570), muscle contraction (GO:0006936), cell-cell junction assembly (GO:0007043), cell-cell signaling (GO:0007267), chemical synaptic transmission (GO:0007268), visual perception (GO:0007601), gap junction assembly (GO:0016264), cell development (GO:0048468), cardiac muscle tissue development (GO:0048738), atrial cardiac muscle cell action potential (GO:0086014), SA node cell to atrial cardiac muscle cell communication by electrical coupling (GO:0086021), AV node cell to bundle of His cell communication by electrical coupling (GO:0086053), cell communication (GO:0007154), heart development (GO:0007507), monoatomic ion transmembrane transport (GO:0034220), transmembrane transport (GO:0055085)
GO Molecular Function (5): monoatomic ion channel activity (GO:0005216), gap junction channel activity (GO:0005243), gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling (GO:0086020), gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling (GO:0086077), protein binding (GO:0005515)
GO Cellular Component (10): nucleoplasm (GO:0005654), endoplasmic reticulum (GO:0005783), endoplasmic reticulum membrane (GO:0005789), plasma membrane (GO:0005886), gap junction (GO:0005921), connexin complex (GO:0005922), intercalated disc (GO:0014704), synapse (GO:0045202), membrane (GO:0016020), anchoring junction (GO:0070161)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Transmission across Electrical Synapses | 1 |
| Gap junction trafficking | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cell differentiation | 2 |
| cell communication by electrical coupling involved in cardiac conduction | 2 |
| cellular process | 2 |
| gap junction channel activity involved in cardiac conduction electrical coupling | 2 |
| cellular anatomical structure | 2 |
| cell junction | 2 |
| blood vessel morphogenesis | 1 |
| muscle system process | 1 |
| cell junction assembly | 1 |
| cell-cell junction organization | 1 |
| cell communication | 1 |
| signaling | 1 |
| anterograde trans-synaptic signaling | 1 |
| sensory perception of light stimulus | 1 |
| cell-cell junction assembly | 1 |
| anatomical structure development | 1 |
| cellular developmental process | 1 |
| heart development | 1 |
| striated muscle tissue development | 1 |
| cardiac muscle cell action potential involved in contraction | 1 |
| atrial cardiac muscle cell to AV node cell signaling | 1 |
| SA node cell to atrial cardiac muscle cell communication | 1 |
| AV node cell to bundle of His cell communication | 1 |
| animal organ development | 1 |
| circulatory system development | 1 |
| monoatomic ion transport | 1 |
| transmembrane transport | 1 |
| transport | 1 |
| monoatomic ion transmembrane transporter activity | 1 |
| channel activity | 1 |
| wide pore channel activity | 1 |
| SA node cell to atrial cardiac muscle cell communication by electrical coupling | 1 |
| AV node cell to bundle of His cell communication by electrical coupling | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
Protein interactions and networks
STRING
586 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GJC1 | GJA1 | P17302 | 984 |
| GJC1 | GJA5 | P36382 | 983 |
| GJC1 | GJB6 | O95452 | 895 |
| GJC1 | TJP1 | Q07157 | 892 |
| GJC1 | GJE1 | A6NN92 | 861 |
| GJC1 | GJA4 | P35212 | 836 |
| GJC1 | HCN4 | Q9Y3Q4 | 823 |
| GJC1 | GJD2 | Q9UKL4 | 775 |
| GJC1 | CNST | Q6PJW8 | 730 |
| GJC1 | MIP | P30301 | 687 |
| GJC1 | TJP3 | O95049 | 651 |
| GJC1 | GJB2 | P29033 | 641 |
| GJC1 | NKX2-5 | P52952 | 624 |
| GJC1 | PANX1 | Q96RD7 | 601 |
| GJC1 | PKP2 | Q99959 | 582 |
IntAct
154 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GJC1 | MEOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJC1 | SLC66A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| APOL3 | GJC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GJC1 | TMEM86A | psi-mi:“MI:0915”(physical association) | 0.560 |
| ADGRG5 | KLRG2 | psi-mi:“MI:0914”(association) | 0.530 |
| ZACN | GPAA1 | psi-mi:“MI:0914”(association) | 0.530 |
| PTGIR | TMEM63A | psi-mi:“MI:0914”(association) | 0.530 |
| SLC22A16 | APBA3 | psi-mi:“MI:0914”(association) | 0.530 |
| NRAS | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.480 |
| GJC1 | HTRA3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJC1 | PDZD2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJC1 | LNX2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJC1 | GORASP2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJC1 | TJP1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJC1 | HTRA1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJC1 | TJP2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJC1 | PARD3B | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJC1 | HTRA4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJC1 | PARD3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJC1 | GORASP1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJC1 | APBA1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJC1 | TJP3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJC1 | GRIP2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJC1 | GRID2IP | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJC1 | HTRA2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJC1 | NHERF4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJC1 | DVL3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJC1 | SCRIB | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJC1 | TIAM2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
BioGRID (68): GJC1 (Affinity Capture-MS), EXTL2 (Affinity Capture-MS), GJC1 (Affinity Capture-MS), GJC1 (Affinity Capture-MS), GJC1 (Reconstituted Complex), UBQLN4 (Affinity Capture-Western), PSMD2 (Affinity Capture-Western), GJC1 (Affinity Capture-MS), GJC1 (Affinity Capture-MS), GJC1 (Affinity Capture-MS), GJC1 (Affinity Capture-MS), GJC1 (Affinity Capture-MS), GJC1 (Affinity Capture-MS), GJC1 (Affinity Capture-MS), GJC1 (Affinity Capture-MS)
ESM2 similar proteins: A0A0U1QT59, A2VEY9, A8X9H4, D3KZG3, O35412, O35607, O57474, O61366, O93383, P18861, P29415, P34535, P36383, P43322, P49414, P50605, P60571, P91682, Q02297, Q03345, Q05199, Q11069, Q13873, Q14693, Q2THW7, Q2THW9, Q2THX1, Q5R838, Q5RJX2, Q5YCC7, Q64448, Q69ZW3, Q6DR98, Q6H1V1, Q6IMP4, Q6TYA8, Q7TQ69, Q7Z5M5, Q86B91, Q8INR6
Diamond homologs: A2VE67, A4GG66, A4GVD1, A4IFL1, A6XKM2, O18968, O54851, O57474, O70610, O75712, O93533, O95377, O95452, P08033, P08034, P08050, P08983, P14154, P16863, P16864, P17302, P18246, P18860, P18861, P21994, P23242, P25305, P28228, P28229, P28230, P28231, P28232, P28233, P28234, P28235, P28236, P29033, P29414, P29415, P33725
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 119 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Ras activation upon Ca2+ influx through NMDA receptor | 7 | 53.3× | 1e-08 |
| Assembly and cell surface presentation of NMDA receptors | 8 | 27.1× | 5e-08 |
| Neurexins and neuroligins | 9 | 23.6× | 2e-08 |
| Negative regulation of MAPK pathway | 5 | 17.7× | 2e-04 |
| Protein-protein interactions at synapses | 5 | 17.7× | 2e-04 |
| RAF/MAP kinase cascade | 8 | 6.5× | 5e-04 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| establishment or maintenance of epithelial cell apical/basal polarity | 9 | 46.7× | 1e-10 |
| protein localization to synapse | 5 | 34.2× | 3e-05 |
| receptor clustering | 6 | 33.4× | 4e-06 |
| regulation of postsynaptic membrane neurotransmitter receptor levels | 5 | 22.1× | 2e-04 |
| protein-containing complex assembly | 9 | 9.2× | 6e-05 |
| cell-cell adhesion | 10 | 9.1× | 2e-05 |
| chemical synaptic transmission | 8 | 5.5× | 4e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
42 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 29 |
| Likely benign | 2 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000005874 (17:44800041 G>A), RS1000037102 (17:44799699 G>T), RS1000167992 (17:44794564 C>T), RS1000176499 (17:44810933 A>G), RS1000228381 (17:44808699 T>C), RS1000330347 (17:44830230 C>A,G,T), RS1000424341 (17:44822922 T>C), RS1000564811 (17:44823172 G>A), RS1000654662 (17:44819515 G>A,C,T), RS1000845493 (17:44804982 A>G), RS1000935713 (17:44831560 G>C), RS1000945602 (17:44798310 G>A,T), RS1000957944 (17:44819293 C>T), RS1000994921 (17:44798576 T>C), RS1001233165 (17:44825719 G>A)
Disease associations
OMIM: gene MIM:608655 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: other ic — Connexins and Pannexins
CTD chemical–gene interactions
59 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases methylation, affects cotreatment, decreases expression, affects expression | 6 |
| Benzo(a)pyrene | affects methylation, decreases expression, decreases methylation | 2 |
| Nickel | decreases expression | 2 |
| Phenylmercuric Acetate | decreases expression, affects cotreatment | 2 |
| Particulate Matter | decreases expression, increases abundance | 2 |
| methylmercuric chloride | decreases expression | 1 |
| bisphenol A | decreases expression | 1 |
| terbufos | decreases methylation | 1 |
| 2,4,5,2’,4’,5’-hexachlorobiphenyl | affects expression | 1 |
| beta-lapachone | decreases expression | 1 |
| zinc chromate | decreases expression, increases abundance | 1 |
| dibenzo(a,l)pyrene | decreases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| fumonisin B1 | decreases expression | 1 |
| chromium hexavalent ion | decreases expression, increases abundance | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| chloropicrin | increases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| erucylphospho-N,N,N-trimethylpropylammonium | increases expression | 1 |
| ICG 001 | increases expression | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | decreases expression, affects cotreatment | 1 |
| SRM 1597 | decreases expression | 1 |
| 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | decreases expression, increases response to substance | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| NSC 689534 | affects binding, decreases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Vorinostat | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Targeted by drugs: Calcium, Carbenoxolone